LGBTQ people live with higher rates of stress and poor treatment in many parts of health care. Cancer clinics often repeat those patterns [1,5-7,35,53,59]. For many readers, this will match things you have seen with your own eyes: how unfair treatment in cancer care harms trust, health, and daily life [1-7,15-16,35-37,53-54,59-61].
Stigma
Stigma means people judge you as less worthy because of who you are. They might see your sexual orientation or gender identity as wrong, dirty, or strange [6,7,36,37]. Discrimination means unfair actions which follow those judgments. Staff might ignore your partner, use the wrong name, or give worse care [4,7,35,37,53].
Unwelcoming settings are places where you feel you must hide or shrink yourself in order to stay safe. This still happens even when no one says anything openly hostile.
The research shows many examples. Patients describe feeling invisible, afraid, or on guard in clinics, hospitals, and imaging centers [3,4,9,10,21,31,35-37,53-54]. These stories appear in surveys, interviews, focus groups, and national samples from several countries [1-3,6,7,15,35-37,,53,59-61].
How unwelcoming settings show up
You often meet the health system first on a form. Many paper and online forms only offer boxes for “male” or “female,” “husband” or “wife,” and leave no clear place for partners, chosen family, or gender diverse people [3-5,9-12,15,26,35]. Some forms never ask about sexual orientation or gender identity at all [1,2,11,16,17,26,59,61]. Such silence sends a strong message.
Waiting rooms also speak. Posters and brochures show straight married couples. No rainbow stickers, no inclusive statements, no words about trans or nonbinary people. You sit in the room and feel sure no one planned for you.
Inside exam rooms, stigma appears in many ways. Staff use the wrong name or pronouns even after you share your identity [13,27,31,35,37,51-53,57,60]. They speak about “husband” or “wife” after you have already said “partner,” “boyfriend,” “girlfriend,” or “spouse” [3,4,10,21,31,35-37,53-54]. Some providers make jokes or comments about LGBTQ people which land as cruel or mocking [13,31,35,37,53]. Others grow tense or change the subject when you mention sex, dating, or gender affirmation [20,25,27,31,34,38,57,59].
Many patients in these studies say staff talk to a straight family member instead of the partner at their side [3,9,12,15,37,54]. Partners often feel treated like visitors, not key members of the care team [12,15,37,40]. For many, this repeats long histories of exclusion.
How stigma harms health and access to care
Stigma and discrimination do not stay at the level of feelings. They change who gets care, when, and how.
Several reviews and surveys show lower or uneven use of cancer screening among sexual and gender minority groups [6-8,21,32,48,55,61,65,66]. This includes breast, cervical, prostate, colorectal, and anal screening [6-8,32,48,55,61,65,66]. People describe fear of poor treatment, discomfort with staff, and confusion about which organs need screening after gender affirming care [6-8,27,32,48,50-51,55-57,60-62,65,66].
Many LGBTQ people delay seeking care when new symptoms appear. Reasons include fear of judgment, past bad experiences, and lack of trust in local services [4,6,7,15,18,21,32,33,36,37,53,60]. Several studies link these delays to more advanced disease at diagnosis and worse outcomes [6,7,15,32,36,43,46,47,52,60,64]. When you have to travel far to find a welcoming clinic, treatment often starts later.
Inside treatment, stigma affects what you share. If you expect bias, you might hide your partner, stay silent about sexual practices, or avoid talking about mental health or substance use [3,9,10,12,20,25,31,35-37,52-54]. Providers then miss key details which shape safe care.
Health literacy in this context
Health literacy means how well you find, understand, and use health information. For LGBTQ people, health literacy sits on top of minority stress.
Oncology teams in many papers report gaps in training on LGBTQ health [6,11,22,24,29-31,34,38,45,59]. Staff often feel unsure how to ask about sex and gender, how to guide trans patients about hormones during treatment, or how to talk about fertility in same sex relationships [6,11,22,24,27,29-31,34,38,45,51,57-59]. When providers feel unsure, they often skip hard topics, speak in vague terms, or give advice based on straight cisgender lives [3-6,9-12,20,24,25,29-31,34,35,38].
Education materials reflect the same pattern. Pamphlets and survivorship plans usually show straight couples and focus on pregnancy, “male” and “female” sex, and narrow family roles [3,9,10,12,20,35-39,52-54,63]. Little content explains sex after treatment for gay men, lesbian couples, bisexual people, or those with queer and fluid identities [9,12,20,25,35-39]. Offices often lack any leaflets on trans health and cancer [27,42,50,51,56-60,62].
Online peer spaces help, yet they also reveal gaps. Studies of LGBTQ survivors in online communities report strong social support alongside limited access to expert input on symptoms, side effects, and safe sexual activity after treatment [9,12,20,35-39,52-54]. People trade advice and stories, although not always with clinical backing.
When you do not see your life reflected in information, health literacy suffers. You receive messages which feel distant or wrong. Over time, many stop asking questions because every answer seems built for someone else.
Intersectional stigma
Stigma rarely targets only one part of a person. Many LGBTQ people in the articles live with racism, poverty, disability, or immigration stress along with homophobia, biphobia, or transphobia [6,7,15,18,36,37,40,43,60,61]. Black, Indigenous, and other people of color describe being ignored or talked down to on top of anti LGBTQ bias [6,15,36,37,40,43,60,61]. Trans women of color in particular report hostile treatment in emergency rooms, imaging suites, and inpatient units [27,42,51,57,60,62].
These layered harms create deeper barriers to care. You might face trouble with health coverage, trouble taking time off from low wage work, and fear of police or immigration officers near hospitals [6,7,15,18,36,37,40,43,60,61]. Financial strain appears in several studies of LGBTQ adolescents and young adults with cancer who report high medical debt and strong links between money stress and poor mental health [40,41]. Many adults share similar worries.
Palliative care, end of life, and clinical trials
Later in the cancer journey, stigma shows up again.
Papers on palliative and end of life care describe low use of these services among LGBTQ patients [28,33]. People fear hospice or palliative teams will ignore partners or chosen family members or block them from the bedside [28,33,37]. Some worry staff will not respect their gender expression when they lose strength [27,28,57,60]. This fear leads many to avoid hospice until the final days or to skip it entirely, even when symptom relief would bring comfort.
Clinical trial access has gaps as well. A number of articles describe “invisibility” of sexual and gender minority patients in cancer studies [1,6,7,24,43,44,48,60-62]. Trials often fail to collect sexual orientation and gender identity data, which hides whether LGBTQ people join or stay in studies [1,17,24,43,44]. Some protocols exclude people with HIV, people on gender affirming hormones, or those with complex mental health histories, which affects many LGBTQ communities [6,7,24,43,44,48,60-62]. Without equal trial access, new treatments reach LGBTQ patients more slowly.
Transgender and gender diverse experiences
Reviews and surveys describe misgendering during imaging, surgery, and inpatient stays [27,42,50,51,56-60,62]. Staff sometimes focus on trans status rather than cancer needs. Some providers refuse hormone therapy during treatment without clear reason or fail to plan around past surgeries [27,42,50,51,56-60,62]. Others treat gender affirming care as an optional extra rather than an essential part of health.
Screening guidance often leaves trans people guessing. Studies point to confusion about mammograms after chest surgery, prostate screening for trans women, and cervical screening for trans men and nonbinary people with a cervix [27,32,42,50-52,55-57,60-62,65,66]. When guidelines do not match lived bodies, both patients and providers struggle to plan.
What helps create welcoming settings
Although many findings are painful, the research also describes features of better care.
Inclusive forms and data systems matter. When clinics ask clear, respectful questions about sexual orientation, gender identity, pronouns, and family structure, LGBTQ patients feel more seen [11,17,22,24,26,35,45,52,59-61]. Staff then have information they need to tailor education and referrals. The ASCO position statement and several reviews highlight routine sexual and gender minority data collection as a core step toward equity [1,5,6,43,45,59-61].
Staff training appears again and again as a key need. Communication skills programs which focus on LGBTQ health improve provider comfort and patient reports of respect [22,24,26,29-31,34,38,45,59]. Oncology nurses and doctors in these programs learn how to ask open questions, how to include partners, and how to respond when a patient shares history of discrimination [22,24,26,29-31,34,38,45,59]. Patients notice and remember these moments.
Policies and leadership also shape care. Statements from groups such as ASCO and ESMO urge cancer centers to name sexual and gender minority health as a priority, measure disparities, and work with community partners [1,42,43,45,51,58,59]. Inclusive hiring, staff support, and strong responses to bias complaints help shift the culture which surrounds each appointment [35,38,45,51,58,59].
Steps you might take as a patient
Responsibility for change sits with systems, not only with you. Even so, personal strategies sometimes reduce harm and open space for better care. Many people in the studies shared steps which helped them feel safer.
Preparation for visits makes a difference. Before appointments, some patients write down main questions, including at least one about how treatment affects sex, relationships, or gender affirmation [3,9,10,12,20,25,31,35-37,52-54]. Many bring a partner or trusted friend to serve as a witness, note taker, and advocate [3,9,12,15,37,40]. Others connect with LGBTQ cancer groups in advance for tips on local providers.
Clear self introduction at check in also helps some people. For example, “My name is Rosa, I use she and they pronouns, this is my wife, Carla.” If staff use the wrong terms, you choose when and how to correct them. Some address issues in the moment. Others wait and speak with a patient advocate or ombudsperson later on [12,21,26,31,35,52,53].
You have the right to respectful care. Many hospitals hold non discrimination policies which include sexual orientation and gender identity [1,11,28,35,43,51,58,59]. Those policies apply to you. You are able to ask to see them and request support if you face harassment or repeated disrespect.
Peer support also plays a special role. Online and in person LGBTQ cancer groups offer spaces where you speak openly about fear, anger, sex, faith, family, and future plans [9,12,20,35-39,52-54]. Members share names of affirming providers, clinic tricks, and language which worked when asking for better treatment. Several studies in your list grew directly from such partnerships [12,35,38,39,52,58,59].
Change often feels slow inside big health systems. Still, many people work for better care. Researchers, advocates, nurses, and doctors from LGBTQ communities use data from these studies to press leaders for action. Every survey response, interview, and focus group in your spreadsheets adds weight to this effort. When you speak up about your experience, you join this growing record.
LGBTQ people with cancer move through health systems shaped by stigma, discrimination, and long histories of erasure [1-7,15-16,35-37,43,52-54,59-61]. These forces influence when you seek help, how staff speak with you, what information you receive, and which treatments reach you.
At the same time, the same research shows paths toward something better. Inclusive forms, trained staff, strong policies, and deep partnership with LGBTQ communities all support safer care [1,5-7,11,22,24,26,29-31,34-39,43,45,51,58,59-61]. Your story, and stories from many others, already sit at the center of this work.
You deserve cancer care where your whole self is welcome, your questions matter, and your relationships count. The evidence supports this goal. Your life does as well.
References
[1] Griggs J, Maingi S, Blinder V, et al. American Society of Clinical Oncology Position Statement: Strategies for Reducing Cancer Health Disparities Among Sexual and Gender Minority Populations. Journal of Clinical Oncology. 2017.
[2] Obedin-Maliver J. Time to Change: Supporting Sexual and Gender Minority People – An Underserved, Understudied Cancer Risk Population. Journal of the National Comprehensive Cancer Network. 2017.
[3] Baughman A, Clark MA, Boehmer U. Experiences and Concerns of Lesbian, Gay, or Bisexual Survivors of Colorectal Cancer. Oncology Nursing Forum. 2017.
[4] Fish J, Williamson I. Exploring lesbian, gay and bisexual patients’ accounts of their experiences of cancer care in the UK. European Journal of Cancer Care. 2016.
[6] Matthews AK, Breen E, Kittiteerasack P. Social Determinants of LGBT Cancer Health Inequities. Seminars in Oncology Nursing. 2018.
[7] Boehmer U. LGBT Populations’ Barriers to Cancer Care. Seminars in Oncology Nursing. 2018.
[8] Ceres M, Quinn GP, Loscalzo M, Rice D. Cancer Screening Considerations and Cancer Screening Uptake for Lesbian, Gay, Bisexual, and Transgender Persons. Seminars in Oncology Nursing. 2018.
[9] Brown MT, McElroy JA. Unmet support needs of sexual and gender minority breast cancer survivors. Supportive Care in Cancer. 2018.
[10] Lisy K, Peters MDJ, Schofield P, Jefford M. Experiences and unmet needs of lesbian, gay, and bisexual people with cancer. Psycho-Oncology. 2018.
[11] Wheldon CW, Schabath MB, Hudson J, et al. Culturally competent care for sexual and gender minority patients at National Cancer Institute-designated comprehensive cancer centers. LGBT Health. 2018.
[12] Seay J, Mitteldorf D, Yankie A, et al. Survivorship care needs among LGBT cancer survivors. Journal of Psychosocial Oncology. 2018.
[13] Bryson MK, Taylor ET, Boschman L, et al. Awkward Choreographies from Cancer’s Margins: Incommensurabilities of LGBTQ+ Patients’ Experiences and the Clinical Research Agenda. Journal of Medical Humanities. 2019.
[15] Kent EE, Wheldon CW, Smith AW, Srinivasan S, Geiger AM. Care delivery, patient experiences, and health outcomes among sexual and gender minority patients with cancer. Cancer. 2019.
[16] Boehmer U, Gereige J, Winter M, Ozonoff A. Cancer survivors’ access to care and quality of life: Do sexual minorities fare worse than heterosexuals. Cancer. 2019.
[17] Schabath MB, Blackburn CA, Sutter ME, et al. National Survey of Oncologists at National Cancer Institute-Designated Comprehensive Cancer Centers: Attitudes, Knowledge, and Practice Behaviors about LGBTQ Patients with Cancer. Journal of Clinical Oncology. 2019.
[18] Langston ME, Fuzzell L, Lewis-Thames MW, Khan S, Moore JX. Disparities in health information-seeking behaviors and fatalistic views of cancer by sexual orientation identity. LGBT Health. 2019.
[19] Charkhchi P, Carlos RC, Chawla N, et al. Modifiers of Cancer Screening Prevention Among Sexual and Gender Minority Populations. Journal of the American College of Radiology. 2019.
[21] Haviland KS, Swette S, Kelechi T, Mueller M. Barriers and Facilitators to Cancer Screening Among LGBTQ Individuals. Oncology Nursing Forum. 2020.
[22] Berner AM, Hughes DJ, Tharmalingam H, et al. An evaluation of self-perceived knowledge, attitudes and behaviours of oncology healthcare professionals about LGBTQ+ cancer patients. ESMO Open. 2020.
[23] Griggs JJ. Improving the Care of Lesbian, Gay, Bisexual, Transgender, and Queer Patients with Cancer: Transformational Approaches. JCO Oncology Practice. 2020.
[24] Quinn GP, Alpert AB, Sutter M, Schabath MB. What Oncologists Should Know About Treating Sexual and Gender Minority Patients with Cancer. JCO Oncology Practice. 2020.
[25] Kamen C, Pratt-Chapman ML, Quinn GP. Sexual health in oncology care for sexual and gender minority cancer patients. Current Sexual Health Reports. 2020.
[26] Banerjee SC, Staley JM, Alexander K, Walters CB, Parker PA. Encouraging patients to disclose their lesbian, gay, bisexual, transgender, and queer identities: Communication strategies for oncology clinicians. Translational Behavioral Medicine. 2020.
[28] Cloyes KG, Candrian C. Palliative and End-of-Life Care for Sexual and Gender Minority Patients with Cancer. Current Oncology Reports. 2020.
[29] Pratt-Chapman ML, Alpert AB, Castillo DA. Health outcomes of sexual and gender minorities after cancer: A systematic review. Systematic Reviews. 2021.
[30] Banerjee SC, Greene K, Fletcher K, et al. Sexual and Gender Minority Communication Skills (SGM Comskil) Training for Oncology Clinicians: A Pilot. Annals of LGBTQ Public and Population Health. 2021.
[31] Sutter ME, Simmons VN, Sutton SK, et al. Oncologists’ experiences caring for LGBTQ patients with cancer: Qualitative analysis. Patient Education and Counseling. 2021.
[32] Ma SJ, Oladeru OT, Bird CE, et al. Prostate Cancer Screening Patterns Among Sexual and Gender Minority Individuals. European Urology. 2021.
[33] Haviland K, Burrows Walters C, Newman S. Barriers to palliative care in sexual and gender minority patients with cancer. Health and Social Care in the Community. 2021.
[34] Ussher JM, Perz J, Allison K, et al. Attitudes, knowledge and practice behaviours of oncology health care providers in regard to LGBTQI patients with cancer. Patient Education and Counseling. 2021.
[35] Ussher JM, Power R, Perz J, et al. LGBTQI Inclusive Cancer Care: A Discourse Analytic Study of Health Care Staff Understandings. Frontiers in Oncology. 2021.
[36] Ussher JM, Perz J, Power R, et al. LGBTQI cancer patients’ quality of life and distress: A comparison with heterosexual cancer patients. Frontiers in Oncology. 2021.
[37] Ussher JM, Perz J, Power R, et al. LGBTQI Cancer Patient and Carer Experiences of Minority Stress and Stigma. Frontiers in Oncology. 2021.
[38] Kano M, Jaffe SA, Rieder S, et al. Improving Sexual and Gender Minority Cancer Care: Patient and Caregiver Perspectives from a Multi-State Needs Assessment Study. Frontiers in Oncology. 2021.
[39] Kamen CS, Hastert TA, Mulvaney M, et al. Community-Driven Identification and Adaptation of a Cancer Care Intervention for Sexual and Gender Minority Patients. Frontiers in Oncology. 2021.
[40] Waters AR, Bybee S, Warner EL, et al. Financial Burden and Mental Health Among LGBTQIA+ Adolescent and Young Adult Cancer Survivors. Frontiers in Oncology. 2021.
[41] Waters AR, Branscum AJ, Miglioretti DL, et al. LGBTQ+ Cancer Survivors’ Psychosocial Well-being: A Cross-sectional Study. Cancer Reports (Hoboken). 2022.
[42] Leone AG, et al. Cancer in Transgender and Gender-Diverse Persons: A Review. JAMA Oncology. 2022.
[43] Jackson SS, et al. Cancer disparities among sexual and gender minority populations. Journal of the National Medical Association. 2022.
[44] Rosser BRS, et al. Sexual and Gender Minority Invisibility in Cancer Studies: A Call for Routine Data Collection. Journal of Clinical Oncology. 2023.
[45] Kamen CS, et al. State of Cancer Care in America: Achieving Cancer Health Equity for Sexual and Gender Minority Communities. JCO Oncology Practice. 2023.
[46] Eckhert E, et al. Breast Cancer Diagnosis, Treatment, and Outcomes of Patients from Sexual and Gender Minority Groups. JAMA Oncology. 2023.
[47] Warwar S, et al. Breast cancer disparities among sexual and gender minority populations. Translational Cancer Research. 2023.
[48] Heer E, et al. Participation, barriers, and facilitators of cancer screening among sexual and gender minorities: A review of the literature. Preventive Medicine. 2023. h
[49] Yang M-J, et al. Psychosocial characteristics and quality of life among sexual and gender minority patients with cancer. JNCI Cancer Spectrum. 2023.
[50] Kyrazis CB, et al. Imaging Care for Transgender and Gender Diverse Patients. RadioGraphics. 2023.
[51] Leone AG, et al. Cancer care in transgender and gender-diverse persons. ESMO Open. 2023. h
[53] Beaton S, et al. Barriers to Cancer Care in the LGBTQ+ Community. Journal of Surgical Oncology. 2023.
[54] Wang YC, et al. Care Needs, Challenges, and Experiences of Sexual and Gender Minority Cancer Survivors: A Qualitative Study. Seminars in Oncology Nursing. 2023.
[55] Tundealao S, et al. Cancer screening among sexual minority groups in the United States. Journal of Medicine, Surgery, and Public Health. 2023.
[56] Carroll EF, et al. Breast care considerations for transgender and gender-diverse patients. Women’s Health. 2023.
[57] Cathcart-Rake EJ, et al. Cancer care for transgender and gender-diverse people: Practice review. CA: A Cancer Journal for Clinicians. 2023.
[58] Barcellini A, et al. Turning lessons into action: Building an inclusive oncology center using the Milano framework. Journal of Cancer Policy. 2024.
[59] Azzellino G, et al. Barriers and Nursing Strategies in Oncology Care for LGBTQIA+ People: A Scoping Review. Cancers. 2024.
[60] Stamm LE, et al. Disparities in the cancer continuum experienced by transgender and gender-diverse patients: A rapid review. Cancer. 2024.
[61] Harris CK, et al. Relationships Among Determinants of Health, Cancer Screening and Sexual Orientation Identity: A Systematic Review. LGBT Health. 2024.
[62] Yang S, et al. The Burden of Cancer and Precancerous Conditions Among Transgender and Gender Diverse Individuals in a Large Health Network: Retrospective Cohort Study. JMIR Cancer. 2024.
[63] Cohen LN, et al. Breast Cancer Disparities in the LGBTQ+ Community: How to Move from Risk to Survivorship. Current Breast Cancer Reports. 2024.
[64] Chan K, et al. Breast Cancer Outcomes in Transgender and Gender-Diverse Patients in the National Cancer Database. JAMA Oncology. 2024.
[65] LeBlanc ME, et al. Advancing equity in cervical cancer screening for sexual and gender minorities. Reproductive Health. 2024.
[66] Sam IT, et al. Barriers and facilitators to anal cancer screening among men from sexual minority populations: A scoping review. BMC Cancer. 2024.